AccessHope Raises $33M in Funding to Expand Cancer Benefit Services
AccessHope Raises $33M in Series B Funding
AccessHope's Series B Funding
Key Highlights:
- Series B Funding: AccessHope, a cancer benefit company, raised $33 million in Series B funding.
- Investors: Backed by City of Hope.
- Growth and Expansion: Funding will be used for product and technology development, oncology network expansion, and entering new markets.
AccessHope's Target Market
- Target Market: AccessHope provides cancer care benefits to approximately seven million members through more than 400 employers, including Fortune 500 companies.
- Employers and HR Departments: Companies seeking to provide comprehensive cancer care benefits to their employees.
- Health Plans and Government Organizations: Expansion into health plans, Medicare, and government organizations to reach a wider audience.
What AccessHope Needs to Buy
- Product and Technology Development: Investments in developing and enhancing their cancer care benefit platform and technology.
- Oncology Network Expansion: Collaborations with additional cancer treatment centers and oncologists to expand their network and expertise.
- Market Entry Strategies: Partnerships and marketing efforts to enter new markets, such as health plans, Medicare, and government organizations.